The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
about
BMI-1 autoantibody as a new potential biomarker for cervical carcinoma.Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.Epigenetic regulation of normal and malignant hematopoiesis.Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.Epigenetic factors in cancer development: polycomb group proteins.JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells.Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2.Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells.Ring1B promotes hepatic stem/progenitor cell expansion through simultaneous suppression of Cdkn1a and Cdkn2a in mice.Cytotoxic T lymphocytes: the future of cancer stem cell eradication?Loss of BMI-1 expression is associated with clinical progress of malignant melanoma.Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation.
P2860
Q34087890-EE9F6AC5-20AB-4FE0-8737-B99FEABD63D1Q34792248-112DBE15-FBC5-43EB-95FB-39B4DF67FDA9Q35042810-8DF22682-0BCD-4DE6-B42C-745AE8DFA736Q35854018-76DE0A5B-0ED2-4E06-862F-9CE599865943Q36667455-A66532F4-979C-4391-BDF7-142C8508B2F3Q36970179-D9C04C92-F57F-43C5-9FB4-BC0FCED42766Q37268297-DA0FACE0-7A93-467A-BE49-B87A676026D5Q37629613-0C10DEDD-B35A-48F1-A922-189AC467A91AQ37773254-06EA35AF-26F4-4E7D-9E06-44D47F358F11Q37822735-F24F0266-4101-4C1F-8EC4-87135FD015AEQ38788734-7693968D-F41D-4F1E-870B-2F58462798F4Q38940136-61CA6EC6-C65B-4C8E-8640-10F820BC876CQ39118411-9158CCA2-B36D-4000-963C-51A1D62A4564Q39575598-106785A5-1723-4DBB-91A4-2EA7FD17B087Q46829705-33BEC0F8-5EEB-4F37-AAF5-097E3A52BB99Q51425747-52F79ACF-4530-432A-B8A5-6CD8F7750CCFQ53500613-B9078A79-ED65-4DFD-8367-A002C1355EC0Q53528762-4A7F1E95-9658-4112-A6C7-E0665DD1C2CB
P2860
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
@ast
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
@en
type
label
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
@ast
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
@en
prefLabel
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
@ast
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
@en
P2093
P2860
P356
P1476
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
@en
P2093
G M Reynolds
J C Steele
K L Noakes
M van Lohuizen
S G Hubscher
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603369
P407
P577
2006-10-03T00:00:00Z